Key Takeaways
- • Private equity firms completed 85% of all mergers and acquisitions in autism services between 2017 and 2022—the highest consolidation rate across all healthcare segments, according to research by Cornell Professor Rosemary Batt.
- • Private equity acquired more than 500 autism therapy centers across 42 states as of 2024, capitalizing on insurance mandate expansions that extended commercial and Medicaid coverage for autism services to nearly all U.S. states by 2019.
- • PE acquisition strategy in autism services relies on leveraged buyouts with substantial debt loaded onto acquired providers, followed by rapid resale to other PE firms on average every four years, extracting multiple reimbursements without proportional service expansion.
- • Research identifies 12 leading autism service providers owned by PE firms that lack prior experience in autism care delivery, prioritizing executive compensation and partner returns over service quality and accessibility improvements.
- • Batt's policy paper calls for legislative monitoring and oversight to protect autism service quality and redirect insurance and taxpayer funding toward intended beneficiaries rather than PE investor returns.
Summary
A policy paper by Rosemary Batt, the Alice Hanson Cook Professor of Women and Work at Cornell University, documents extensive private equity consolidation in autism services and raises concerns about capital extraction at the expense of service quality. The research, co-authored with Eileen Appelbaum of the Center for Economic and Policy Research, reveals that between 2017 and 2022, private equity firms completed 85% of all mergers and acquisitions in autism services—a concentration level unmatched in any other healthcare sector.
This PE influx followed two decades of advocacy that fundamentally expanded the market for autism services. Before 2001, neither commercial health insurance nor Medicaid covered autism treatments. By 2015, all but seven states had enacted insurance mandates requiring commercial plans to cover autism services, with full national coverage achieved by 2019. The resulting flow of insurance and taxpayer funding created a multi-billion-dollar market that attracted significant PE investment. As of 2024, private equity firms owned more than 500 autism therapy centers spanning 42 states.
The research examined 12 leading autism service providers owned by major PE firms—conglomerates with extensive healthcare and non-healthcare holdings but minimal operational experience in autism care. The acquisition model relied on leverage: PE buyers loaded substantial debt onto acquired providers, then rapidly resold them to other PE firms, with average holding periods of approximately four years. This strategy generated multiple rounds of transaction fees and returns while extracting reimbursements without commensurate service expansion or quality improvements.
Batt characterized the dynamic as a misalignment between parental advocacy goals and PE execution: "Parents who fought for health insurance coverage for their autistic kids expected the funds to be used to expand access to high-quality treatment. They didn't expect firms to move in, skim reimbursements to pay high salaries to executives, and deliver millions to private equity partners." The paper calls for legislation providing monitoring and oversight mechanisms to ensure autism service funding advances treatment quality and access rather than functioning as a capital extraction vehicle for PE investors.
This PE influx followed two decades of advocacy that fundamentally expanded the market for autism services. Before 2001, neither commercial health insurance nor Medicaid covered autism treatments. By 2015, all but seven states had enacted insurance mandates requiring commercial plans to cover autism services, with full national coverage achieved by 2019. The resulting flow of insurance and taxpayer funding created a multi-billion-dollar market that attracted significant PE investment. As of 2024, private equity firms owned more than 500 autism therapy centers spanning 42 states.
The research examined 12 leading autism service providers owned by major PE firms—conglomerates with extensive healthcare and non-healthcare holdings but minimal operational experience in autism care. The acquisition model relied on leverage: PE buyers loaded substantial debt onto acquired providers, then rapidly resold them to other PE firms, with average holding periods of approximately four years. This strategy generated multiple rounds of transaction fees and returns while extracting reimbursements without commensurate service expansion or quality improvements.
Batt characterized the dynamic as a misalignment between parental advocacy goals and PE execution: "Parents who fought for health insurance coverage for their autistic kids expected the funds to be used to expand access to high-quality treatment. They didn't expect firms to move in, skim reimbursements to pay high salaries to executives, and deliver millions to private equity partners." The paper calls for legislation providing monitoring and oversight mechanisms to ensure autism service funding advances treatment quality and access rather than functioning as a capital extraction vehicle for PE investors.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.